Medpace Holdings

MEDP · NASDAQ · USD

598,08 $Variazione rispetto alla chiusura precedente: −4,18%Variazione assoluta: −26,10 $

Chiusura · 1 ottobre 2026

Profilo dell'azienda

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Descrizione disponibile in inglese.

Dati societari

Settore
Salute
Industria
Diagnostics & Research
Sede
5375 Medpace Way, 45227, Cincinnati
Dipendenti
6.500
Quotazione
MEDP · NASDAQ
Valuta
USD
Sito web
medpace.com